-
Topics
- Academics
- Accreditation
- Addiction
- Allergies
- Alzheimer's
- Artificial Intelligence
- Awards & Recognition
- Behavioral Health
- Breast Health
- Cardiology
- Career Opportunities
- Clinical Trials
- COVID-19
- Dermatology
- Diabetes
- Diet & Nutrition
- Diversity
- Ear Nose & Throat
- Education
- Emergency Medicine
- Ethics
- Events
- Family Medicine
- Gastroenterology
- Gene Therapy
- Geriatrics
- Gifts & Donations
- Home health care
- Immunology
- Infectious Diseases
- Innovation
- Integrative Medicine
- Leadership
- Medical devices
- Men's Health
- Mental Health
- Neurology
- Neurosurgery
- Nursing
- Oncology
- Ophthalmology
- Orthopedics
- Otolaryngology
- Partnerships
- Pediatrics
- Physical therapy
- Podiatry
- Population Health
- Pulmonology
- Radiation oncology
- Radiology
- Rare Diseases
- Reproductive Health
- Research
- Respiratory disease
- Robotics
- Safety
- Sleep
- Sports Medicine
- Stroke
- Surgery
- Sustainability
- Technology
- Transplantation
- Urology
- Women's Health
-
Categories
- Cutler Center for Men
- Drusinsky Sports Medicine Institute
- Harrington Discovery Institute
- Harrington Heart & Vascular Institute
- Haslam Sports Innovation Center
- Nursing
- Rainbow Babies & Children's Hospital
- Seidman Cancer Center
- UH Transplant Institute
- UH Behavioral Health Institute
- UH Center for Orthopedics
- UH Community Hospitals
- UH Connor Whole Health
- UH Ear, Nose & Throat Institute
- UH Eye Institute
- UH Neurological Institute
- UH Primary Care Institute
- UH Research & Education Institute
- UH Urology Institute
- UH Ventures
Ophthalmology
Showing of 1 results
Harrington Discovery Institute Scholar Successfully Moves New Drug for Rare, Genetic Eye Disease into Clinical Trial
Richard Kramer, PhD, hopes to help patients with retinitis pigmentosa.
8/8/2022 By Ansley Kelm
Results are loading...